Roger Michael Gendreau

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ Greg Duncan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Michael Gendreau:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dogwood Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to buy) 82,500 05 Mar 2026 Direct

Insider Reports Filed by Roger Michael Gendreau

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DWTX Dogwood Therapeutics, Inc. 05 Mar 2026 1 $0 4 CHIEF MEDICAL OFFICER 06 Mar 2026, 16:17
DWTX Dogwood Therapeutics, Inc. 04 Dec 2025 1 $0 4 CHIEF MEDICAL OFFICER 05 Dec 2025, 16:05
DWTX Dogwood Therapeutics, Inc. 27 Jun 2025 1 $0 4 CHIEF MEDICAL OFFICER 01 Jul 2025, 14:11
DWTX Virios Therapeutics, Inc. 26 Feb 2024 1 $0 4 CHIEF MEDICAL OFFICER 28 Feb 2024, 12:43
DWTX Virios Therapeutics, Inc. 12 Dec 2022 1 $0 4 CHIEF MEDICAL OFFICER 14 Dec 2022, 17:30
DWTX Virios Therapeutics, Inc. 23 Jun 2022 1 $0 4 CHIEF MEDICAL OFFICER 30 Jun 2022, 13:53